XTNT vs. ATAI
XTNT (Xtant Medical Holdings, Inc.) and ATAI (Atai Life Sciences N.V.) are both stocks. Both are in the Healthcare sector — XTNT in Medical Devices, ATAI in Biotechnology. Over the past 5 years, XTNT returned -24.04%/yr vs -25.61%/yr for ATAI. At a 0.14 correlation, their price movements are largely independent.
Performance
XTNT vs. ATAI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XTNT achieves a -45.47% return, which is significantly lower than ATAI's 0.24% return.
XTNT
- 1D
- -1.95%
- 1M
- -10.94%
- YTD
- -45.47%
- 6M
- -45.19%
- 1Y
- -27.54%
- 3Y*
- -19.19%
- 5Y*
- -24.04%
- 10Y*
- -33.15%
ATAI
- 1D
- 1.23%
- 1M
- -5.09%
- YTD
- 0.24%
- 6M
- -5.31%
- 1Y
- 102.97%
- 3Y*
- 38.30%
- 5Y*
- -25.61%
- 10Y*
- —
XTNT vs. ATAI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
XTNT Xtant Medical Holdings, Inc. | -45.47% | 76.98% | -60.80% | 71.21% | 17.86% | -67.44% |
ATAI Atai Life Sciences N.V. | 0.24% | 207.52% | -5.67% | -46.99% | -65.14% | -63.67% |
Correlation
The correlation between XTNT and ATAI is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Jun 18, 2021 | 0.14 |
Fundamentals
XTNT:
$0.09
ATAI:
-$2.67
XTNT:
0.32
ATAI:
292.00
XTNT:
$133.93M
ATAI:
$3.49M
XTNT:
$84.27M
ATAI:
$3.49M
XTNT:
$22.15M
ATAI:
-$663.38M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XTNT vs. ATAI — Risk / Return Rank
XTNT
ATAI
XTNT vs. ATAI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Xtant Medical Holdings, Inc. (XTNT) and Atai Life Sciences N.V. (ATAI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XTNT | ATAI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.78 | ||
| Sortino ratioReturn per unit of downside risk | -2.65 | ||
| Omega ratioGain probability vs. loss probability | 0.96 | 1.27 | -0.31 |
| Calmar ratioReturn relative to maximum drawdown | -0.52 | 2.15 | -2.67 |
| Martin ratioReturn relative to average drawdown | -0.90 | 3.38 | -4.28 |
Loading charts...
Drawdowns
XTNT vs. ATAI - Drawdown Comparison
The maximum XTNT drawdown since its inception was -99.17%, roughly equal to the maximum ATAI drawdown of -95.05%. Use the drawdown chart below to compare losses from any high point for XTNT and ATAI.
Loading charts...
Drawdown Indicators
| XTNT | ATAI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.17% | -95.05% | -4.12% |
Max Drawdown (1Y)Largest decline over 1 year | -53.53% | -48.06% | -5.47% |
Max Drawdown (3Y)Largest decline over 3 years | -74.78% | -59.23% | -15.55% |
Max Drawdown (5Y)Largest decline over 5 years | -82.47% | -94.66% | +12.19% |
Max Drawdown (10Y)Largest decline over 10 years | -98.54% | — | — |
Current DrawdownCurrent decline from peak | -98.99% | -80.48% | -18.51% |
Average DrawdownAverage peak-to-trough decline | -88.79% | -80.78% | -8.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.67% | 30.58% | +0.09% |
Volatility
XTNT vs. ATAI - Volatility Comparison
The current volatility for Xtant Medical Holdings, Inc. (XTNT) is 8.02%, while Atai Life Sciences N.V. (ATAI) has a volatility of 19.36%. This indicates that XTNT experiences smaller price fluctuations and is considered to be less risky than ATAI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XTNT | ATAI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.02% | 19.36% | -11.34% |
Volatility (6M)Calculated over the trailing 6-month period | 32.99% | 50.22% | -17.23% |
Volatility (1Y)Calculated over the trailing 1-year period | 59.59% | 80.92% | -21.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 73.59% | 83.61% | -10.02% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 113.47% | 83.59% | +29.88% |
Dividends
XTNT vs. ATAI - Dividend Comparison
Neither XTNT nor ATAI has paid dividends to shareholders.
Financials
XTNT vs. ATAI - Financials Comparison
This section allows you to compare key financial metrics between Xtant Medical Holdings, Inc. and Atai Life Sciences N.V.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
XTNT and ATAI have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ATAI has higher volatility (19.36%) compared to XTNT (8.02%). In terms of maximum drawdown, XTNT dropped -99.17% vs ATAI's -95.05%.
ATAI currently has the higher Sharpe Ratio (1.32 vs -0.46), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XTNT and ATAI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer